axitinib,sunitinib,pembrolizumab
merck,pfizer
['kn-42', 'kn-426']
5 year results of kn-426 11% absolute difference of pfs at 5 years orr 60%, cr 11.6% 4.8% absolute difference of os at 5 years in itt population #asco23 
On the road! Medical Oncologist & Prof @AnkaraUni | GU cancer expert  🔬| Diversity & Equity 📢 Advocate 💫  🌍 #Oncology #GenitourinaryCancer